Synergistic effects of injection of bone marrow cells into both portal vein and bone marrow on tolerance induction in transplantation of allogeneic pancreatic islets

We have established a new method for allogeneic pancreatic islet ( PI) transplantation: relatively low doses of irradiation followed by simultaneous transplantation of PIs and bone marrow cells (BMCs) via the portal vein (PV). In the present study, we have compared this method with intra-bone marrow (IBM)-bone marrow transplantation (BMT), and with a combination of both methods. Streptozotocin (STZ)-induced diabetic-recipient rats, Fischer 344 ( F344, RT1A(1), RT1B(1)), were irradiated 1 day before transplantation. PIs of Brown Norway rats (BN, RT1A(n), RT1B(n)) were transplanted into the liver of the diabetic F344 rats via the PV. BMCs from BN rats were injected into the recipients' bone marrow ( IBM), PV or intravenously (IV) or by a simultaneous combination of PV plus IBM (PV+IBM). We compared graft survival among the groups of '9Gy+IBM'(10/10 accepted), '9Gy + PV'( 7/10 accepted), '9 Gy + IV'(0/7 accepted), '9 Gy + PV + IBM'(8/8 accepted), '8.5 Gy+ IBM'(4/9 accepted), '8.5 Gy + PV'(0/7 accepted), '8.5 Gy + IV'(0/7 accepted), '8.5 Gy + PV + IBM'(9/12 accepted), '8 Gy + IBM' (2/10 accepted) and '8 Gy + PV + IBM' (2/8 accepted). As we reported previously, PV-BMT is more effective in inducing the acceptance of allogeneic PIs than IV-BMT. However, IBM-BMT requires less pretreatment than PV-BMT. (PV + IBM)-BMT was found to be the most effective in inducing the acceptance of allogeneic PIs. These results suggest that allogeneic PI-transplantation in conjunction with (PV + IBM)- BMT could become a viable strategy.